Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran

Journal de Mycologie Medicale

Volumn 24, Issue 2, 2014, Pages

  Razzaghi Abyaneh, M ^a   Sadeghi, G ^a   Zeinali, E ^a   Alirezaee, M ^a   Shams Ghahfarokhi, M ^b   Amani, A ^a   Mirahmadi, R ^a   Tolouei, R ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Antifungal drugs; Broth microdilution; Candida species; Candidiasis; CHROMagar Candida; Disk diffusion

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN; VORICONAZOLE; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA INTERMEDIA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA SAKE; CANDIDA TROPICALIS; CANDIDIASIS; CHILD; CONTROLLED STUDY; DISK DIFFUSION; DRUG POTENCY; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; IN VITRO STUDY; IRAN; MAJOR CLINICAL STUDY; NONHUMAN; PICHIA GUILLIERMONDII; SACCHAROMYCETALES; SPECIES DISTRIBUTION; SUPERFICIAL CANDIDIASIS; VERY ELDERLY; ANTIFUNGAL RESISTANCE; DRUG EFFECTS; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; OUTPATIENT; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA INTERMEDIA; CANDIDA PARAPSILOSIS; CANDIDA SAKE; CANDIDA TROPICALIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INFANT; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; OUTPATIENTS; YOUNG ADULT;

EID: 84902535322     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2014.01.004     Document Type: Article

References (40)

1. Abbasi S., Sabokbar A., Bayat M., Kordbacheh P., Bahonar A. Separating and recognizing Candida species from patients associated with acute vulvovaginitis and candidal recurrent at health-treatment center of Karaj hospital. Middle-East J Sci Res 2011, 7:1014-1018.
2. Aghamirian M.R., Ghiasian S.A. Onychomycosis in Iran: epidemiology, causative agent and clinical features. Jpn J Med Mycol 2010, 51:23-29.
3. Arikan S., Ostrosky-Zeichner L., Lozano-Chiu M., Paetznick V., Gordon D. In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates. J Clin Microbiol 2002, 14:1406-1412.
4. Badiee P., Alborzi A., Davarpanah M.A., Shakiba E. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iranian Med 2010, 13:282-287.
5. Barry A.L., Pfaller M.A., Rennie R.P., Fuchs P.C., Brown S.D. Precision and accuracy of 5- flucytosine susceptibility testing by broth microdilution, E-test, and disk diffusion methods. Antimicrob Agents Chemother 2002, 46:1781-1784.
6. CBS- KNAW Fungal Biodiversity Centre. http://www.cbs.knaw.nl/collections/BioloMICS.aspx?Table=Yeasts%20species&Name=Candida%20intermedia&Fi lds=All&EXACTMATCH=T;2014.
7. Cetinkaya Z., Altindis M., Aktepe O.C., Karabicak N. Comparison of different methods for the identification of Candida species isolated from clinical specimens. Mikrob Bull 2003, 37:269-276.
8. Clinical Laboratory Standards Institute (CLSI) Method for antifungal disk diffusion susceptibility testing of yeasts. Approved standard M44-A 2011.
9. Clinical Laboratory Standards Institute (CLSI) CLSI reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Approved Standard, CLSI document M27-A2 2011.
10. Colombo A.L., Guimaraes T., Aranha Camargo L.F., Richtmann R. Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: sociedade brasileira de infectologia, sociedade paulista de infectologia and sociedade brasileira de medicina tropical. Infect Dis 2013, 17:283-312.
11. Cornet M., Sendid B., Fradin C., Gaillardin C. Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods. J Mol Diagn 2011, 13:12-22.
12. Ellepola A.N., Samaranayake L.P. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000, 11:172-198.
13. Esmaeilzadeh S., Mahdavi Omran S., Rahmani Z. Frequency and etiology of vulvovaginal candidiasis in women referred to a gynecological center in Babol, Iran. Int J Fertil Steril 2009, 3:74-77.
14. Feglo P.K., Narkwa P. Prevalence and antifungal susceptibility patterns of yeast isolates at the Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. Br Microbiol Res J 2012, 2:10-22.
15. Goswami D., Rabha B., Baruah S., Lourembam S.D., Sawian C.E., Baruah D. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral 5-flucytosine therapy. J Infect 2006, 52:111-117.
16. Ilkit M. Onychomycosis in Adana, Turkey: a 5-year study. Int J Dermatol 2005, 44:851-854.
17. Ilkit M., Hilmioglu S., Tasbakan M., Aydemir S. Evaluation of Albicans ID2 and Biggy agar for the isolation and direct identification of vaginal yeast isolates. Med Microbiol 2007, 56:762-765.
18. Jautova J., Viragova M., Ondrasovic E., Holoda E. Incidence of Candida species isolated from human skin and nails: a survey. Folia Microbiol 2001, 46:333-337.
19. Jindal N., Gill P., Aggarwal A. An epidemiological study of vulvovaginal candidiasis in women of childbearing age. Indian J Med Microbiol 2007, 25:175-176.
20. Kabli S.A. In vitro susceptibilities of clinical yeast isolates to antifungal drugs of polyene, pyrimidine, and azoles, and their effect in yeast adhesion and mycelial formation. Saudi J Biol Sci 2008, 15:189-198.
21. Kalkanci A., Berk E., Aykan B., Caglar K., Hizel K. Epidemiology and antifungal susceptibility of Candida species isolated from hospitalized patients. J Mycol Med 2007, 17:16-20.
22. Kovacicova G., Krupova Y., Lovaszova M., Roidova A., Trupl J., Liskova A., et al. Antifungal susceptibility of 262bloodstream yeast isolation from a mixed cancer and non-cancer patient population: is there a correlation between in vitro resistance to 5-flucytosine and the outcome of fungemia?. J Infect Chemother 2000, 6:216-219.
23. Lyon G.M., Karatela S., Sunay S., Adiri Y. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol 2010, 48:1270-1275.
24. Mahmoudi Rad M., Zafarghandi A.S., Amel Zabihi M., Mirdamadi Y., Rahbarian N., Abbasabadi B., et al. Identification of Candida species associated with vulvovaginal candidiasis by multiple PCR method. Infect Dis Obstet Gynecol 2012, [Article ID 872169, doi:10.1155/2012/872169].
25. Mandviwala T., Shinde R., Kalra A., Sobel J.D., Akins R.A. High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of amplicons. J Mol Diagn 2010, 12:91-101.
26. Manzano-Gayosso P., Mendez-Tovar L.J., Arenas R., Hernandez-Hernandez F., Millan-Chio B., Torres-Rodriguez J.M. Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds. Rev Iberoam Micol 2011, 28:32-35.
27. Nazeri M., Mesdaghinia E., Moraveji S.A.R., Atabakhshiyan R., Soleymani F. Prevalence of vulvovaginal candidiasis and frequency of Candida species in women referred to gynecology obstetrics clinic at Kashan-Iran since 2008 to 2010. J Mazand Univ Med Sci 2012, 22:262-269.
28. Negri M., Henriques M., Svidzinski T.I.E. Correlation between Etest, disk diffusion and microdilution method for antifungal susceptibility testing of Candida species from infection and colonization. J Clin Lab Anal 2009, 23:324-330.
29. Olaya-Abril A., Jimenez-Munguia I., Gomez-Gascon L., Rodriguez-Ortega M.J. Surfomics: shaving live organisms for a fast proteomics identification of surface proteins. J Proteomics 2014, 97:164-176.
30. Peman J., Canton E., Quindos G., Eraso E., Alcoba J., Yague G. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012, 67:1181-1187.
31. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Messer S.A., Houston A., et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000, 44:747-751.
32. Pfaller M.A., Messer S.A., Boyken L., et al. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. tested by clinical and laboratory standards institute-recommended broth microdilution methods. J Clin Microbiol 2007, 45:70-75.
33. Rajinder Capoor M., Nair D., Deb M., Kumar Verma P., Srivastava L., Aggarwal P. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Jpn J Infect Dis 2005, 58:344-348.
34. Roderick J.H. The management of superficial candidiasis. J Am Acad Dermatol 1999, 40:S35-S42.
35. Sadeghi G., Abouei M., Alirezaee M., Tolouei R., Shams-Ghahfarokhi M., Mostafavi M., et al. A 4-year survey of dermatomycoses in Tehran from 2006 to 2009. J Mycol Med 2011, 21:260-265.
36. Shokohi T., Bandalizadeh Z., Hedayati M.T., Mayahi S. In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents. Jundishapur J Microbiol 2011, 4:S19-S26.
37. Silva A.P., Miranda I.M., Lisboa C., Pina-Vas C., Rodrigues A.G. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, C.orthopsilosis and C.metapsilosis in a tertiary care hospital. J Clin Microbiol 2009, 47:2392-2397.
38. Zaini F., Gerami Shoar M., Kordbacheh P., Khedmati E., Safara M., Gharaeian N. Performance of five phenotypical methods for identification of Candida isolates from clinical materials. Iranian J Publ Health 2006, 35:25-32.
39. Zaini F., Mahmoudi M., Mehbod A.S.A., Kordbacheh P., Safara M. Fungal nail infection in Tehran, Iran. Iranian J Publ Health 2009, 38:46-53.
40. Zomorodian K., Rahimi M.J., Pakshir K., Motamedi M., Ghiasi M.R., Rezashah H. Determination of antifungal susceptibility pattern among the clinical isolates of Candida species. J Global Infect Dis 2011, 3:357-360.